Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Witte

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Progress in Clinical and Biological Research|January 1, 1984
Behavioural voltammetry: its application in aggression researchJ Mos, M M Witte, B Olivier, et al.
Neurology|March 29, 2007
AMPA potentiator treatment of cognitive deficits in Alzheimer diseaseA S Chappell, C Gonzales, J Williams, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 13, 2010
Assessing the infrequent oral supplementation of olanzapine long-acting injection in the treatment of schizophreniaH Ascher-Svanum, X Peng, W Montgomery, et al.
The Pharmacogenomics Journal|May 20, 2009
Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophreniaB A Fijal, B J Kinon, S Kapur, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Progress in Clinical and Biological Research|January 1, 1984
Behavioural voltammetry: its application in aggression researchJ Mos, M M Witte, B Olivier, et al.
Neurology|March 29, 2007
AMPA potentiator treatment of cognitive deficits in Alzheimer diseaseA S Chappell, C Gonzales, J Williams, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 13, 2010
Assessing the infrequent oral supplementation of olanzapine long-acting injection in the treatment of schizophreniaH Ascher-Svanum, X Peng, W Montgomery, et al.
The Pharmacogenomics Journal|May 20, 2009
Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophreniaB A Fijal, B J Kinon, S Kapur, et al.
Pageof 2